AR011278A1 - Una composicion y un medicamento que comprenden derivados amino acidos y un factor neutrofico para estimular el crecimiento de neuritas en celulasnerviosas - Google Patents

Una composicion y un medicamento que comprenden derivados amino acidos y un factor neutrofico para estimular el crecimiento de neuritas en celulasnerviosas

Info

Publication number
AR011278A1
AR011278A1 ARP970105318A ARP970105318A AR011278A1 AR 011278 A1 AR011278 A1 AR 011278A1 AR P970105318 A ARP970105318 A AR P970105318A AR P970105318 A ARP970105318 A AR P970105318A AR 011278 A1 AR011278 A1 AR 011278A1
Authority
AR
Argentina
Prior art keywords
branched
straight
alkyl
alkenyl
alkynyl
Prior art date
Application number
ARP970105318A
Other languages
English (en)
Spanish (es)
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25009484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR011278(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of AR011278A1 publication Critical patent/AR011278A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP970105318A 1996-11-13 1997-11-13 Una composicion y un medicamento que comprenden derivados amino acidos y un factor neutrofico para estimular el crecimiento de neuritas en celulasnerviosas AR011278A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/748,447 US5840736A (en) 1996-11-13 1996-11-13 Methods and compositions for stimulating neurite growth

Publications (1)

Publication Number Publication Date
AR011278A1 true AR011278A1 (es) 2000-08-16

Family

ID=25009484

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105318A AR011278A1 (es) 1996-11-13 1997-11-13 Una composicion y un medicamento que comprenden derivados amino acidos y un factor neutrofico para estimular el crecimiento de neuritas en celulasnerviosas

Country Status (32)

Country Link
US (3) US5840736A (enExample)
EP (1) EP0946190B1 (enExample)
JP (1) JP2001504470A (enExample)
KR (1) KR100544451B1 (enExample)
CN (1) CN1168442C (enExample)
AP (1) AP9901518A0 (enExample)
AR (1) AR011278A1 (enExample)
AT (1) ATE250424T1 (enExample)
AU (1) AU724833B2 (enExample)
BG (1) BG64670B1 (enExample)
BR (1) BR9712765A (enExample)
CA (1) CA2270634A1 (enExample)
CO (1) CO4930260A1 (enExample)
CZ (1) CZ296058B6 (enExample)
DE (1) DE69725169T2 (enExample)
DK (1) DK0946190T3 (enExample)
EA (1) EA004247B1 (enExample)
ES (1) ES2206753T3 (enExample)
HU (1) HU226728B1 (enExample)
IL (1) IL129555A (enExample)
IN (1) IN183740B (enExample)
IS (1) IS2057B (enExample)
NO (1) NO328030B1 (enExample)
NZ (1) NZ335394A (enExample)
PL (1) PL190903B1 (enExample)
PT (1) PT946190E (enExample)
SK (1) SK284535B6 (enExample)
TR (1) TR199901034T2 (enExample)
TW (1) TW513302B (enExample)
UA (1) UA63926C2 (enExample)
WO (1) WO1998020891A1 (enExample)
ZA (1) ZA9710256B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6852496B1 (en) * 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) * 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
JP2002516904A (ja) 1998-06-03 2002-06-11 ジーピーアイ ニル ホールディングス インコーポレイテッド Ｎ−複素環式カルボン酸またはカルボン酸等配電子体のｎ−結合スルホンアミド
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
WO2000004020A1 (en) 1998-07-17 2000-01-27 Agouron Pharmaceuticals, Inc. Compounds, compositions, and methods for stimulating neuronal growth and elongation
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
AU2173400A (en) * 1998-12-09 2000-06-26 Chiron Corporation Method for administering agents to the central nervous system
AU2407400A (en) * 1999-01-08 2000-07-24 Vertex Pharmaceuticals Incorporated Process for the formation of intermediates useful for the preparation of pharmaceuticals
EP1196389A1 (en) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
US6734211B1 (en) 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
NZ516888A (en) * 1999-07-30 2004-02-27 Vertex Pharma Acyclic and cyclic amine derivatives
DE60029985T2 (de) * 1999-11-12 2007-02-01 Alcon Inc. Verwendung von neurophilin liganden zur behandlung von augenerkrankungen
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
US7060676B2 (en) * 1999-12-20 2006-06-13 Trustees Of Tufts College T. cruzi-derived neurotrophic agents and methods of use therefor
ATE319712T1 (de) 1999-12-21 2006-03-15 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
ATE554784T1 (de) * 2001-05-25 2012-05-15 Cornell Res Foundation Inc Hochaffiner ligand für p75 neurotrophin-rezeptor
JP2005500270A (ja) * 2001-05-29 2005-01-06 ギルフォード ファーマシュウティカルズ インコーポレイテッド 手術の結果として発生した神経損傷を治療するための方法
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US20100247483A1 (en) * 2001-11-13 2010-09-30 Tran Loi H Therapeutic agent composition and method of use
CA2466701C (en) * 2001-11-13 2013-11-12 Loi Tran Neuroprotective use of cyclic prolyl glycine
US7232798B2 (en) 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
CN101400367A (zh) * 2006-02-02 2009-04-01 瑞纳神经科学公司 施用trkb激动剂治疗不希望的重量减轻或进食障碍的方法
CA2637707A1 (en) * 2006-02-02 2007-08-09 Rinat Neuroscience Corporation Methods for treating obesity by administering a trkb antagonist
WO2008078179A1 (en) * 2006-12-20 2008-07-03 Rinat Neuroscience Corporation Trkb agonists for treating autoimmune disorders
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
WO2019222339A1 (en) 2018-05-15 2019-11-21 Tran Lloyd Hung Loi Therapeutic agent composition and method of use, for treatment of mild cognitive impairment, depression, and psychological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US9604852B2 (en) * 2012-09-28 2017-03-28 Dic Corporation α-alumina particles and method for manufacturing the same

Also Published As

Publication number Publication date
CA2270634A1 (en) 1998-05-22
HU226728B1 (en) 2009-08-28
CZ168399A3 (cs) 1999-08-11
ES2206753T3 (es) 2004-05-16
US5840736A (en) 1998-11-24
BR9712765A (pt) 1999-10-26
US6284778B1 (en) 2001-09-04
AU5258998A (en) 1998-06-03
CN1239433A (zh) 1999-12-22
CN1168442C (zh) 2004-09-29
DE69725169T2 (de) 2004-07-15
EP0946190A1 (en) 1999-10-06
DE69725169D1 (de) 2003-10-30
NO328030B1 (no) 2009-11-16
SK62899A3 (en) 2000-04-10
BG64670B1 (bg) 2005-11-30
ZA9710256B (en) 1998-05-28
HUP0001219A3 (en) 2001-12-28
CO4930260A1 (es) 2000-06-27
EA004247B1 (ru) 2004-02-26
PT946190E (pt) 2004-02-27
PL190903B1 (pl) 2006-02-28
NZ335394A (en) 2000-06-23
AP9901518A0 (en) 1999-06-30
HK1022851A1 (en) 2000-08-25
SK284535B6 (sk) 2005-06-02
EP0946190B1 (en) 2003-09-24
US6172086B1 (en) 2001-01-09
IS5032A (is) 1999-04-21
NO992138D0 (no) 1999-05-03
EA199900464A1 (ru) 2000-02-28
JP2001504470A (ja) 2001-04-03
KR100544451B1 (ko) 2006-01-24
CZ296058B6 (cs) 2006-01-11
PL333270A1 (en) 1999-11-22
UA63926C2 (uk) 2004-02-16
AU724833B2 (en) 2000-09-28
IN183740B (enExample) 2000-04-01
TW513302B (en) 2002-12-11
BG103429A (en) 2000-04-28
ATE250424T1 (de) 2003-10-15
TR199901034T2 (xx) 1999-07-21
DK0946190T3 (da) 2003-12-08
KR20000068962A (ko) 2000-11-25
IS2057B (is) 2005-10-14
IL129555A (en) 2005-08-31
WO1998020891A1 (en) 1998-05-22
HUP0001219A2 (hu) 2000-11-28
NO992138L (no) 1999-07-13
IL129555A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
AR011278A1 (es) Una composicion y un medicamento que comprenden derivados amino acidos y un factor neutrofico para estimular el crecimiento de neuritas en celulasnerviosas
MX9203677A (es) Derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
AR008680A1 (es) Substitutos de plaquetas y metodos de conjugacion apropiados para su preparacion
ES2116131T3 (es) Derivados de naftaleno, su procedimiento de preparacion y productos intermediarios adecuados, y las composiciones farmaceuticas que los contienen.
MX173140B (es) Derivados aromaticos y heterociclicos de carboxamida, utiles como agentes antitumorales y procedimiento para su preparacion
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
PT1061940E (pt) Utilizacao de foliestatina para a producao de um medicamento para o tratamento de disturbios relacionados com os musculos
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
NO931526L (no) Cykliske iminoderivater, fremgangsmaate for deres fremstilling, og legemiddelpreparater inneholdende dem
AR016875A1 (es) Un amino-derivado que posee actividad neuronal, una composicion que lo contiene y usos de los mismos para estimular la actividad neuronal
ES2058244T3 (es) Procedimiento para produccion de avermectinas y cultivos para el mismo.
ES2150445T3 (es) Medicamento anti-isquemico.
IL124563A (en) 5-phenyl-3-(substituted oximino) pyrrolo [3, 2-h] isoquinoline-2-one derivatives pharmaceutical compositions containing them and their preparation
ES2120992T3 (es) Derivados de 1-metilcarbapenemo, su preparacion y su uso como antibioticos.
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
ZA200108283B (en) Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs.
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
DK0907646T3 (da) Dihydrobenzopyren og lignende forbindelser anvendelige som middel mod betændelse
AR016382A1 (es) Uso de un derivado del acido bencil-indazol metoxialcanoico.
CO4230037A1 (es) Composicion para aplicacion topica a la piel y/o cabello a base de tensioactivo de fosfato y co-tensioactivo
PT701449E (pt) Processo de preparacao de uma forma de dosagem solida oral contendo diclofenac
ES2098403T3 (es) Derivados de la imidazoindolizina y procedimiento para su preparacion.
DK1069912T3 (da) Injicerbare IGF-formuleringer, der indeholder succinat som puffermiddel
AR008695A1 (es) Composiciones farmaceuticas estabilizadas, basadas en la asociacion de quinupristina / dalfopristina; procedimiento para prepararlas, utilizacion dedichas composiciones y utilizacion del acido metansulfonico o del acido clorhidrico en la estabilizacion de dichas composiciones.
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure